CYCLERION THERAPEUTICS, INC. (KRSA) Operating cash flow 2018–2025
CYCLERION THERAPEUTICS, INC. (KRSA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.3MFY2025 · since FY2018: -$97.5M → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.3M | +23.5% |
| FY2024 | -$4.3M | +79.6% |
| FY2023 | -$21.2M | +47.7% |
| FY2022 | -$40.6M | -11.2% |
| FY2021 | -$36.5M | +49.6% |
| FY2020 | -$72.5M | +29.1% |
| FY2019 | -$102.2M | -4.8% |
| FY2018 | -$97.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KRSA financial trends
KRSA RevenueKRSA Net incomeKRSA Net marginKRSA Gross profitKRSA Gross marginKRSA Operating incomeKRSA Operating marginKRSA Free cash flowKRSA Capital expendituresKRSA Return on equityKRSA Stock buybacksKRSA Dividends paidKRSA Total assetsKRSA Total liabilitiesKRSA Shareholders’ equityKRSA overview →